Literature DB >> 31710715

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels.

Stephen P H Alexander1, Alistair Mathie2, John A Peters3, Emma L Veale2, Jörg Striessnig4, Eamonn Kelly5, Jane F Armstrong6, Elena Faccenda6, Simon D Harding6, Adam J Pawson6, Joanna L Sharman6, Christopher Southan6, Jamie A Davies6.   

Abstract

The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.14749. Ion channels are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2019, and supersedes data presented in the 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
© 2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31710715      PMCID: PMC6844578          DOI: 10.1111/bph.14749

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  145 in total

Review 1.  Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives.

Authors:  Robson da Costa; Giselle F Passos; Nara L M Quintão; Elizabeth S Fernandes; João Raphael L C B Maia; Maria Martha Campos; João B Calixto
Journal:  Br J Pharmacol       Date:  2020-06-03       Impact factor: 8.739

2.  Inflammation induces developmentally regulated sumatriptan inhibition of spinal synaptic transmission.

Authors:  Bryony L Winters; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-07-08       Impact factor: 8.739

3.  Interactions between cannabidiol and Δ9 -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome.

Authors:  Lyndsey L Anderson; Ivan K Low; Iain S McGregor; Jonathon C Arnold
Journal:  Br J Pharmacol       Date:  2020-07-27       Impact factor: 8.739

Review 4.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

5.  Fulditoxin, representing a new class of dimeric snake toxins, defines novel pharmacology at nicotinic ACh receptors.

Authors:  Chun Shin Foo; Chacko Jobichen; Varuna Hassan-Puttaswamy; Zoltan Dekan; Han-Shen Tae; Daniel Bertrand; David J Adams; Paul F Alewood; J Sivaraman; Selvanayagam Nirthanan; R Manjunatha Kini
Journal:  Br J Pharmacol       Date:  2020-02-09       Impact factor: 8.739

6.  Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs.

Authors:  Vivian Wan Yu Liao; Ali Saad Kusay; Thomas Balle; Philip Kiaer Ahring
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

7.  Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation.

Authors:  Ana Carolina Moreira Souza; Andrea Grabe-Guimarães; Jader Dos Santos Cruz; Artur Santos-Miranda; Charlotte Farah; Liliam Teixeira Oliveira; Alexandre Lucas; Franck Aimond; Pierre Sicard; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

Review 8.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

9.  The hyperpolarization-activated cyclic nucleotide-gated 4 channel as a potential anti-seizure drug target.

Authors:  Qays Kharouf; A Marie Phillips; Lauren E Bleakley; Emma Morrisroe; Julia Oyrer; Linghan Jia; Andreas Ludwig; Liang Jin; Joseph A Nicolazzo; Elisabetta Cerbai; M Novella Romanelli; Steven Petrou; Christopher A Reid
Journal:  Br J Pharmacol       Date:  2020-06-17       Impact factor: 8.739

10.  Prenatal and postnatal alcohol exposure increases vulnerability to cocaine addiction in adult mice.

Authors:  Lídia Cantacorps; Sandra Montagud-Romero; Miguel Ángel Luján; Olga Valverde
Journal:  Br J Pharmacol       Date:  2020-01-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.